Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia [0.03%]
伊马替尼耐药性在慢性粒细胞白血病中的替代抑制剂研究综述
Roberta Bitencourt,Ilana Zalcberg,Iúri Drumond Louro
Roberta Bitencourt
The development of point mutations in the BCR-ABL kinase domain is the main reason for imatinib resistance in chronic myeloid leukemia. Different detection methods are used in chronic myeloid leukemia monitoring, such as direct sequencing, ...
Rodolfo Delfini Cançado,Manuel Muñoz
Rodolfo Delfini Cançado
Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia (IDA) because of its effectiveness and low cost. But unfortunately in many iron deficient conditions, oral iron is a less than the ideal treat...
The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era [0.03%]
酪氨酸激酶抑制剂时代慢性粒细胞白血病主要分子反应和稳定分子反应的意义
Ilana Zalcberg Renault,Vanesa Scholl,Rocio Hassan et al.
Ilana Zalcberg Renault et al.
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular responses to tyrosine kinase inhibitors. Molecular monitoring repr...
Hematology in Latin America: where are we? Analysis of the reports of Societies of Hematology associated organization of the Highlights of ASH in Latin America [0.03%]
拉美地区血液学发展现状分析——基于ASH年会收录的拉美地区各国血学会报告
Raul Gabús,Sebastian Galeano,Carmino Antonio de Souza et al.
Raul Gabús et al.
Nelson Falsarella,Ana Iara da Costa Ferreira,Fabiana Nakashima et al.
Nelson Falsarella et al.
Objective: The aim of this study was to verify if ABO phenotypes are associated with allergic rhinitis. Methods: 168 patients with alle...
Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia [0.03%]
硫酸铁治疗成人缺铁性贫血的有效性和安全性
Rodolfo Delfini Cançado,Pedro Otavio Novis de Figueiredo,Maria Cristina Albe Olivato et al.
Rodolfo Delfini Cançado et al.
Background: Iron deficiency is the most common disorder in the world, affecting approximately 25% of the world`s population and the most common cause of anemia. ...
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas [0.03%]
巴西大剂量连续化疗联合自体造血干细胞移植治疗恶性淋巴瘤的经验
Bruno Kosa Lino Duarte,Eliana Cristina Martins Miranda,Marcio Nucci et al.
Bruno Kosa Lino Duarte et al.
Objective: To evaluate the use of high-dose sequential chemotherapy in a Brazilian population. Methods: High-dose cyclophosphamide foll...
Karyotypic and fluorescent in situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms [0.03%]
染色体7着丝粒在继发性髓系肿瘤中的核型和荧光原位杂交研究
Roberta Sandra da Silva Tanizawa,Cristina Aiko Kumeda,Raymundo Soares de Azevedo Neto et al.
Roberta Sandra da Silva Tanizawa et al.
Background: Secondary myeloid neoplasms comprise a group of secondary diseases following exposure to myelotoxic agents or due to congenital diseases. The improvement of anticancer agents and immunosuppressive drugs seem t...
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia [0.03%]
染色体和JAK2及MPL基因突变与原发性血小板增多症、真性红细胞增多症和原发性骨髓纤维化之间的关系
Leonardo Caires Dos Santos,Juliana Corrêa da Costa Ribeiro,Neusa Pereira Silva et al.
Leonardo Caires Dos Santos et al.
Background: The detection of molecular and cytogenetic alterations is important for the diagnosis, prognosis and classification of myeloproliferative neoplasms. ...
Mobilization of hematopoietic progenitor cells with granulocyte colony stimulating factors for autologous transplant in hematologic malignancies: a single center experience [0.03%]
造血生长因子促造血前体细胞动员自体移植治疗血液系统恶性肿瘤的单中心经验
Raul Gabús,Gabriel Borelli,Martín Ferrando et al.
Raul Gabús et al.
Background: In 2006 the Hematology Service of Hospital Maciel published its experience with peripheral blood progenitor cell harvesting for autologous stem cell transplantation using Filgen JP (Clausen Filgrastim). After ...